Louisiana Community-Engagement Alliance Against COVID-19 Disparities (LA-CEAL): Impact of HALT COVID Ambassador Program on Likelihood to Vaccinate
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 56
- 试验地点
- 2
- 主要终点
- Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 1
研究概览
简要总结
The purpose of the study is to assess the effectiveness of the HALT COVID Ambassador educational outreach program on increasing likelihood to vaccinate against COVID-19
详细描述
Investigators will use a randomized controlled trial to test the effectiveness of HALT COVID educational outreach by HALT COVID Ambassadors. HALT COVID Ambassadors will receive training to answer common vaccine questions & address misconceptions; conduct motivational interviewing; and implement basic behavioral economics and related strategies to remove barriers to vaccination. A random sample of FQHC patients will be identified in EHR data downloads of adult patients seen in the last year and contacted by telephone to gain consent and assess eligibility. A total of 100 individuals will be enrolled into the trial and randomized to intervention (engagement with the HALT COVID Ambassador over a 1 month period via in-person or virtual sessions exploring their own questions and concerns about vaccines) or usual care (no extra engagement). Baseline, 1-month, and 2-month follow-up surveys will assess for vaccine likelihood.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Unlikely to vaccinate in next month
- •Age >=18 years
- •Self-identification as Black or African American
- •Ability to understand and speak English
- •Willingness to engage with HALT COVID Ambassador via in-person or virtual sessions exploring questions and concerns about vaccines
排除标准
- •Unable or unwilling to give informed consent
结局指标
主要结局
Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 1
时间窗: Month 1 follow-up
Vaccine likelihood will be measured using a single question adapted from the CEAL Common Survey (i.e., "On a scale from 1 to 7, with 1 being 'not at all likely' and 7 being 'very likely', how likely are you to get a COVID-19 vaccine in the next month?"), with "likely to vaccinate" defined as a score of 5-7.
次要结局
- Difference in Proportion of Participants Who Have Received >=1 Dose of Vaccine Between Study Arms at Month 2(Month 2 follow-up)
- Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 2(Month 2 follow-up)
- Difference in Proportion of Participants Who Have Received >=1 Dose of Vaccine Between Study Arms at Month 1(Month 1 follow-up)